Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways.
Angelo, Laura S
Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. [electronic resource] - Molecular cancer therapeutics Nov 2011 - 2094-103 p. digital
Publication Type: Journal Article
1538-8514
10.1158/1535-7163.MCT-11-0243 doi
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Benzhydryl Compounds--pharmacology
Cell Line, Tumor
Cell Proliferation--drug effects
Curcumin--pharmacology
Drug Resistance, Neoplasm--genetics
Drug Synergism
Gene Expression Regulation, Neoplastic--drug effects
HSP72 Heat-Shock Proteins--genetics
Heat-Shock Proteins--antagonists & inhibitors
Humans
Myosin-Light-Chain Phosphatase--metabolism
Neurofibromatosis 2--drug therapy
Neurofibromin 2--metabolism
Phosphorylation
Protein Binding
Pyrrolidinones--pharmacology
Signal Transduction--drug effects
Up-Regulation--drug effects
Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways. [electronic resource] - Molecular cancer therapeutics Nov 2011 - 2094-103 p. digital
Publication Type: Journal Article
1538-8514
10.1158/1535-7163.MCT-11-0243 doi
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Benzhydryl Compounds--pharmacology
Cell Line, Tumor
Cell Proliferation--drug effects
Curcumin--pharmacology
Drug Resistance, Neoplasm--genetics
Drug Synergism
Gene Expression Regulation, Neoplastic--drug effects
HSP72 Heat-Shock Proteins--genetics
Heat-Shock Proteins--antagonists & inhibitors
Humans
Myosin-Light-Chain Phosphatase--metabolism
Neurofibromatosis 2--drug therapy
Neurofibromin 2--metabolism
Phosphorylation
Protein Binding
Pyrrolidinones--pharmacology
Signal Transduction--drug effects
Up-Regulation--drug effects